Literature DB >> 12072945

Prevalence of genotypic resistance in untreated HIV patients in Spain.

J M Eiros1, C Labayru, B Hernández, M Ortega, P Bachiller, R Ortiz de Lejarazu.   

Abstract

The aims of this retrospective study were to assess the prevalence of primary genotypic resistance to antiretroviral drugs in untreated HIV patients in Spain using the line probe assay and to determine its possible relationship to several epidemiological variables. The global prevalence of primary resistance was 12.5%. Primary mutations in the reverse transcriptase gene were found in two (2.2%) samples: M41L, K70R and M184 V were found in one sample and K70R in another. Primary mutations in the protease gene were detected in 12% of cases; V82A was the mutation most frequently detected (11/12, 91.6%). No statistical significance was found for any of the epidemiological variables studied. In conclusion, the prevalence of primary resistance detected is similar to that found by other authors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072945     DOI: 10.1007/s10096-002-0711-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

1.  HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

Authors:  Somnuek Sungkanuparph; Rebecca Oyomopito; Sunee Sirivichayakul; Thira Sirisanthana; Patrick C K Li; Pacharee Kantipong; Christopher K C Lee; Adeeba Kamarulzaman; Liesl Messerschmidt; Matthew G Law; Praphan Phanuphak
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

2.  The Role of Baseline HIV-1 Resistance Testing in Patients with Established Infection.

Authors:  Suk-Yin Chan; Todd Hulgan; Richard T. D'Aquila
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

3.  Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.

Authors:  Sasisopin Kiertiburanakul; Romanee Chaiwarith; Sunee Sirivichayakul; Rossana Ditangco; Awachana Jiamsakul; Patrick C K Li; Pacharee Kantipong; Christopher Lee; Winai Ratanasuwan; Adeeba Kamarulzaman; Annette H Sohn; Somnuek Sungkanuparph
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.